Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. Neumann O, Burn TC, Allgauer M, Ball M, et al. Br J Cancer 2022;127:1540-1549.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Neumann O, Burn TC, Allgauer M, Ball M, et al. Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. Br J Cancer 2022;127:1540-1549.
PMID: 35871236